Biggest changeExcluding the settlement with DOE, gross profit from the Technical Solutions segment decreased by $10.7 million (or 535%), mainly due to a $21.3 million decrease in gross profit generated for the accrued loss related to Phase 1 of the HALEU Operation Contract, partially offset by a $10.1 million increase in gross profit generated from the HALEU Demonstration Contract. 56 Non-Segment Information The following tables present elements of the accompanying consolidated statements of operations that are not categorized by segment (dollar amounts in millions): Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 Year Ended December 31, 2022 2021 $ Change % Change Gross profit $ 117.9 $ 114.5 $ 3.4 3 % Advanced technology costs 14.8 2.1 12.7 605 % Selling, general and administrative 33.9 36.0 (2.1) (6) % Amortization of intangible assets 9.0 8.1 0.9 11 % Special charges for workforce reductions 0.5 — 0.5 n/a Operating income 59.7 68.3 (8.6) (13) % Nonoperating components of net periodic benefit income (6.6) (67.6) 61.0 90 % Interest expense 0.5 0.1 0.4 400 % Investment income (2.0) (0.1) (1.9) (1,900) % Income before income taxes 67.8 135.9 (68.1) (50) % Income tax expense (benefit) 15.6 (39.1) 54.7 140 % Net income $ 52.2 $ 175.0 $ (122.8) (70) % Advanced Technology Costs Advanced technology costs were $14.8 million and $2.1 million for the year ended December 31, 2022 and 2021, respectively, an increase of $12.7 million (or 605%).
Biggest changeThe change was attributable to an increase in gross profit generated from the HALEU Operation Contract and other contracts of $26.0 million and $1.5 million, respectively, partially offset by a $7.8 million decrease in gross profit generated from the HALEU Demonstration Contract. 65 Non-Segment Information The following table presents elements of the accompanying Consolidated Statements of Operations that are not categorized by segment (dollar amounts in millions): Year Ended December 31, 2023 Compared with Year Ended December 31, 2022 Year Ended December 31, 2023 2022 $ Change % Change Gross profit $ 112.1 $ 117.9 $ (5.8) (5) % Advanced technology costs 14.2 14.8 (0.6) (4) % Selling, general and administrative 35.6 33.9 1.7 5 % Amortization of intangible assets 6.3 9.0 (2.7) (30) % Special charges for workforce reductions 3.6 0.5 3.1 620 % Operating income 52.4 59.7 (7.3) (12) % Nonoperating components of net periodic benefit income (23.2) (6.6) (16.6) (252) % Interest expense 1.3 0.5 0.8 160 % Investment income (8.7) (2.0) (6.7) (335) % Other income, net (1.5) — (1.5) n/a Income before income taxes 84.5 67.8 16.7 25 % Income tax expense 0.1 15.6 (15.5) (99) % Net income $ 84.4 $ 52.2 $ 32.2 62 % Amortization of Intangible Assets Amortization of intangible assets was $6.3 million and $9.0 million for the year ended December 31, 2023 and 2022, respectively, a decrease of $2.7 million (or 30%).
Our agreements with electric utilities are primarily medium and long-term fixed-commitment contracts under which our customers are obligated to purchase a specified quantity of the SWU component of LEU from us.
Our agreements with electric utilities are primarily medium-term and long-term fixed-commitment contracts under which our customers are obligated to purchase a specified quantity of the SWU component of LEU from us.
For the year ended December 31, 2022, income tax expense consists of federal tax of $14.9 million, permanent differences of $3.5 million, and state income tax expense of $0.7 million.
For the year ended December 31, 2022, income tax expense consists of federal income tax of $14.9 million, permanent differences of $3.5 million, and state income tax expense of $0.7 million.
In our Technical Solutions segment, the majority of our contractual commitments were entered into as a result of contracts we have with our U.S. Government customers. The U.S.
In our Technical Solutions segment, the majority of our contractual commitments were entered into as a result of contracts we have with our U.S. government customers.
Government generally would be required to pay us for any costs we incur relative to these commitments if they were to terminate the related contracts “for convenience” under the FAR, subject to available funding. This also would be true in cases where we perform subcontract work for a prime contractor under a U.S. Government contract.
The U.S. government generally would be required to pay us for any costs we incur relative to these commitments if they were to terminate the related contracts “for convenience” under the FAR, subject to available funding. This also would be true in cases where we perform subcontract work for a prime contractor under a U.S. government contract.
The following chart summarizes long-term and spot SWU price indicators, and a spot price indicator for UF 6 , as published by TradeTech, LLC in Nuclear Market Review : SWU and Uranium Market Price Indicators* * Source: Nuclear Market Review , a TradeTech publication, www.uranium.info Our contracts with customers are denominated primarily in U.S. dollars, and, although revenue has not been materially affected by changes in the foreign exchange rate of the U.S. dollar, we may have a competitive price advantage or disadvantage obtaining new contracts in a competitive bidding process depending upon the weakness or strength of the U.S. dollar.
The following chart summarizes long-term and spot SWU price indicators, and a spot price indicator for UF 6 , as published by TradeTech, LLC in Nuclear Market Review : SWU and Uranium Market Price Indicators* * Source: Nuclear Market Review , a TradeTech publication, www.uranium.info 58 Our contracts with customers are denominated primarily in U.S. dollars, and, although revenue has not been materially affected by changes in the foreign exchange rate of the U.S. dollar, we may have a competitive price advantage or disadvantage obtaining new contracts in a competitive bidding process depending upon the weakness or strength of the U.S. dollar.
Additional terms and conditions of the 8.25% Notes are described in Note 8, Debt, of the Consolidated Financial Statements in Part IV of this Annual Report. 63 2021 Tender Offer On October 20, 2021, the Company announced the commencement of a tender offer to purchase all of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (the “Series B Senior Preferred Stock”), at a price of $1,145.20 per Series B Senior Preferred Stock (inclusive of any rights to accrued but unpaid dividends), to the sellers in cash, less any applicable withholding taxes (the “Offer”).
Additional terms and conditions of the 8.25% Notes are described in Note 8, Debt, of the Consolidated Financial Statements in Part IV of this Annual Report. 2021 Tender Offer On October 20, 2021, the Company announced the commencement of a tender offer to purchase all of its outstanding Series B Senior Preferred Stock, par value $1.00 per share (the “Series B Senior Preferred Stock”), at a price of $1,145.20 per share (inclusive of any rights to accrued but unpaid dividends), to the sellers in cash, less any applicable withholding taxes (the “Offer”).
For uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date. Intangible assets originated from our reorganization and application of fresh start accounting as of September 30, 2014. The intangible assets represented the fair value adjustment to the assets and liabilities for our LEU segment.
For uranium not under contract, the estimated selling price is based primarily on published price indicators at the balance sheet date. 60 Intangible assets originated from our reorganization and application of fresh start accounting as of September 30, 2014. The intangible assets represented the fair value adjustment to the assets and liabilities for our LEU segment.
The termination for convenience language also may be included in contracts with foreign, state and local governments. We also have contracts with customers that do not include termination for convenience provisions, including contracts with commercial customers. In our LEU segment, we have long-term inventory purchase agreements with TENEX and Orano that extend to 2028 and 2030, respectively.
The termination for convenience language also may be included in contracts with foreign, state and local governments. We also have contracts with customers that do not include termination for convenience provisions, including contracts with commercial customers. 74 In our LEU segment, we have long-term inventory purchase agreements with TENEX and Orano that extend to 2028 and 2030, respectively.
As a result of these regulations, the standalone selling price of products or services in the Company’s contracts with the U.S. Government are 50 typically equal to the selling price stated in the contract. The Company does not contemplate future modifications, including unexercised options until they become legally enforceable.
As a result of these regulations, the standalone selling price of products or services in the Company’s contracts with the U.S. government are typically equal to the selling price stated in the contract. The Company does not contemplate future modifications, including unexercised options until they become legally enforceable.
The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract.
The Company recognizes revenue over time as it performs on these contracts because of the continuous transfer of control to the customer. 59 The Company determines the transaction price for each contract based on the consideration it expects to receive for the products or services being provided under the contract.
Market prices for SWU and uranium significantly declined from 2011 until mid-2018, when they began to trend upward. More recently, market uncertainty in the wake of the Russian invasion of Ukraine has driven SWU and uranium prices sharply higher.
Market prices for SWU and uranium hexafluoride significantly declined from 2011 until mid-2018, when they began to trend upward. More recently, market uncertainty in the wake of the Russian invasion of Ukraine has driven SWU and uranium hexafluoride prices sharply higher.
Conversely, total estimated costs may decrease if the estimated total costs to complete the contract increase. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly.
Conversely, total estimated costs may increase if the estimated total costs to complete the contract increase. As a significant change in one or more estimates could affect the profitability of the Company’s contracts, the Company reviews and updates its contract-related estimates regularly.
Revenue from the sale of SWU under such contracts is recognized at the time LEU is delivered and is based on the fair value of the natural uranium at contract inception, or as the quantity of natural uranium is finalized, if variable.
Revenue from the sale of SWU under such contracts is recognized at the time LEU is delivered and is based on the fair value of the natural uranium hexafluoride at contract inception, or as the quantity of natural uranium hexafluoride is finalized, if variable.
Operating Results Our revenues, operating results, and cash flows can fluctuate significantly from quarter to quarter and year to year. Our Order Book in the LEU segment consists primarily of long-term, fixed commitment contracts, and we have visibility on a significant portion of our revenue for 2023-2026.
Operating Results Our revenues, operating results, and cash flows can fluctuate significantly from quarter to quarter and year to year. Our Order Book in the LEU segment consists primarily of long-term, fixed commitment contracts, and we have visibility on a significant portion of our revenue for 2024-2026.
Refer to Note 2, Revenue and Contracts with Customers, in the Consolidated Financial Statements in Part IV of this Annual Report for further details. 48 Our financial performance over time can be affected significantly by changes in prices for SWU and natural uranium.
Refer to Note 2, Revenue and Contracts with Customers, in the Consolidated Financial Statements in Part IV of this Annual Report for further details. Our financial performance over time can be affected significantly by changes in prices for SWU and natural uranium hexafluoride.
Components of retirement benefit expense/income other than service cost are presented in our consolidated statement of operations as Nonoperating Components of Net Periodic Benefit Income . These components consist primarily of the return on plan assets, offset by interest cost as the discounted present value of benefit obligations nears payment.
Components of retirement benefit expense/income other than service cost are presented in our Consolidated Statements of Operations as Nonoperating Components of Net Periodic Benefit Income . These components consist primarily of the return on plan assets, offset by interest cost as the discounted present value of benefit obligations nears payment.
Changes in actuarial assumptions could impact the measurement of benefit obligations and benefit costs, as follows: • The expected return on benefit plan assets is approximately 6.8% for 2023. The expected return is based on historical returns and expectations of future returns for the composition of the plans’ equity and debt securities.
Changes in actuarial assumptions could impact the measurement of benefit obligations and benefit costs, as follows: • The expected return on benefit plan assets is approximately 6.8% for 2024. The expected return is based on historical returns and expectations of future returns for the composition of the plans’ equity and debt securities.
However, the net impact of any changes in the expected return on benefit plan assets on the final benefit cost recognized for fiscal year 2023 would be $0 since the actual return on assets would effectively be reflected at December 31, 2023, under our mark-to-market accounting methodology. 52 • The present value of pension obligations is calculated by discounting long-term obligations using a market interest rate.
However, the net impact of any changes in the expected return on benefit plan assets on the final benefit cost recognized for fiscal year 2024 would be $0 since the actual return on assets would effectively be reflected at December 31, 2024, under our mark-to-market accounting methodology. • The present value of pension obligations is calculated by discounting long-term obligations using a market interest rate.
Cost of sales for SWU and natural uranium is based on the amount of SWU and natural uranium sold and delivered during the period and unit inventory costs. Unit inventory costs are determined using the average cost method. Changes in purchase costs have an effect on inventory costs and cost of sales.
Cost of sales for SWU and uranium is based on the amount of SWU and uranium hexafluoride sold and delivered during the period and unit inventory costs. Unit inventory costs are determined using the average cost method. Changes in purchase costs have an effect on inventory costs and cost of sales.
This discount rate is the estimated rate at which the benefit obligations could be effectively settled on the measurement date and is based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plan. Discount rates of approximately 5.5% were used as of December 31, 2022.
This discount rate is the estimated rate at which the benefit obligations could be effectively settled on the measurement date and is based on yields of high quality fixed income investments whose cash flows match the timing and amount of expected benefit payments of the plan. Discount rates of approximately 5.2% were used as of December 31, 2023.
For the year ended December 31, 2022, nonoperating components of net periodic benefit income consists primarily of ($164.1) million related to the increase in discount rates, offset by a loss of $137.0 million on plan assets and $20.5 million of additional costs which include interest costs amortized during the year.
For the year ended December 31, 2022, nonoperating components of net periodic benefit income consist primarily of ($164.1) million related to an increase in discount rates, offset by a loss of $137.0 million on plan assets and $20.5 million of additional costs which include interest costs amortized during the year.
The state income tax expense for the year ended December 31, 2022 and 2021, pr imarily relates to an accrual for a current unrecognized tax benefit offset by the reversal of a previously accrued unrecognized tax benefit.
The state income tax expense for the year ended December 31, 2023 and 2022, pr imarily relates to an accrual for a current unrecognized tax benefit offset by the reversal of a previously accrued unrecognized tax benefit.
Off-Balance Sheet Arrangements Other than our SWU purchase commitments and the license agreement with the DOE relating to the American Centrifuge technology, there were no material off-balance sheet arrangements at December 31, 2022.
Off-Balance Sheet Arrangements Other than our SWU purchase commitments and the license agreement with the DOE relating to the American Centrifuge technology, there were no material off-balance sheet arrangements at December 31, 2023.
New Accounting Standards Reference is made to New Accounting Standards in Note 1, Summary of Significant Accounting Policies, of the Consolidated Financial Statements in Part IV of this Annual Report for information on new accounting standards. 65
New Accounting Standards Reference is made to New Accounting Standards in Note 1, Summary of Significant Accounting Policies, of the Consolidated Financial Statements in Part IV of this Annual Report for information on new accounting standards. 75
Further, sanctions by the United States, Russia or other countries may impact our ability and cost to transport, export, import, take delivery, or make payments related to the LEU we purchase, or make timely deliveries to our customers, and may require us to increase purchases from non-Russian sources to the extent available.
Further, sanctions by the United States, Russia or other countries may impact our ability and cost to transport, export, import, take delivery, or make payments related to the LEU we purchase and may require us to increase purchases from non-Russian sources to the extent available.
Given the current uncertainty and disruption in the market, due to among other things, the war in Ukraine, we are no longer providing guidance on our results of operations for 2023. Please see Forward Looking Statements at the beginning of this Annual Report on Form 10-K. Our Order Book in the LEU segment extends to 2029.
Given the current uncertainty and disruption in the market, due to among other things, the war in Ukraine, we are no longer providing guidance on our results of operations for 2024. Please see Forward Looking Statements at the beginning of this Annual Report on Form 10-K. Our Order Book in the LEU segment extends to 2030.
Under the HALEU Demonstration Contract, Centrus was engaged by the DOE to construct a cascade of sixteen AC100M centrifuges in Piketon to demonstrate HALEU production.
Under the HALEU Demonstration Contract, Centrus was engaged by the DOE to construct a cascade of 16 AC100M centrifuges in Piketon to demonstrate HALEU production.
Our view of liquidity is dependent on, among other things, conditions affecting our operations, including market, international trade restrictions, COVID-19 and other conditions, the level of expenditures and government funding for our services contracts, and the timing of customer payments.
Our view of liquidity is dependent on, among other things, conditions affecting our operations, including market, international trade restrictions, sanctions and other conditions, the level of expenditures and government funding for our services contracts, and the timing of customer payments.
Our Technical Solutions segment reflects our technical, manufacturing, engineering, and operations services offered to public and private sector customers, including engineering and testing activities as well as technical and resource support currently being performed by the Company. This includes the HALEU Demonstration Contract, the HALEU Operation Contract, and a variety of other contracts with public and private sector customers.
Our Technical Solutions segment reflects our technical, manufacturing, engineering, and operations services offered to public and private sector customers, including engineering and testing activities as well as technical and resource support currently being performed by the Company. This includes the HALEU Operation Contract and other contracts with public and private sector customers.
Deployment of new capacity ultimately could replace Russian enrichment but this capacity will take a number of years and significant funding from private or government sources to come on line.
Deployment of new capacity ultimately could replace Russian enrichment but this capacity will take a number of years and significant funding from private or government sources to come online.
We believe our investments in our enrichment technology and the HALEU demonstration will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels, and also offer potential cost synergies for a return to LEU production.
We believe our investments in advanced enrichment technology and our progress in demonstrating HALEU production will position the Company to meet the needs of government and commercial customers in the future as they deploy advanced reactors and next generation fuels and also offers potential cost synergies for a return to LEU production.
Liquidity requirements for our existing operations are affected primarily by the timing and amount of customer sales and our inventory purchases. The Company believes our Order Book in our LEU segment is a source of stability for our liquidity position.
Liquidity requirements for our existing operations are affected primarily by the timing and amount of customer sales and our inventory purchases. We believe our Order Book in our LEU segment is a source of stability for our liquidity position.
As of December 31, 2022 and December 31, 2021, our Order Book was approximately $1.0 billion.
As of December 31, 2023 and December 31, 2022, our Order Book was approximately $1.0 billion.
The change in cash, cash equivalents and restricted cash from our Consolidated Statements of Cash Flows are as follows on a summarized basis (in millions): Year Ended December 31, 2022 2021 Cash provided by operating activities $ 20.6 $ 50.0 Cash used in investing activities (0.7) (1.2) Cash used in financing activities (4.3) (9.9) Increase in cash, cash equivalents and restricted cash $ 15.6 $ 38.9 Operating Activities During 2022, net cash provided by operating activities was $20.6 million.
The change in cash, cash equivalents and restricted cash from our Consolidated Statements of Cash Flows are as follows on a summarized basis (in millions): Year Ended December 31, 2023 2022 Cash provided by operating activities $ 9.1 $ 20.6 Cash used in investing activities (1.6) (0.7) Cash provided by (used in) financing activities 13.9 (4.3) Increase in cash, cash equivalents and restricted cash $ 21.4 $ 15.6 Operating Activities During 2023, net cash provided by operating activities was $9.1 million.
We have a SWU supply agreement, nominally commencing in 2023, with prices payable in a combination of U.S. dollars and euros, but with a contract-defined exchange rate. On occasion, we will accept payment for SWU in the form of natural uranium.
We have a SWU supply agreement that commenced in 2023, with prices payable in a combination of U.S. dollars and euros, but with a contract-defined exchange rate. On occasion, we will accept payment for SWU in the form of natural uranium hexafluoride.
Actual results could differ significantly from the results discussed in the forward-looking statements particularly in light of the economic, social and market uncertainty created by, among other things, the COVID-19 pandemic, including emerging variants, and the war in Ukraine. See “Forward-Looking Statements” at the beginning of this Annual Report on Form 10-K.
Actual results could differ significantly from the results discussed in the forward-looking statements particularly in light of the economic, social and market uncertainty created by, among other things, the war in Ukraine. See “Forward-Looking Statements” at the beginning of this Annual Report on Form 10-K.
The Order Book is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries, and includes approximately $319 million of deferred revenue and advances from customers as of December 31, 2022, whereby customers have made advance payments to be applied against future deliveries. No orders in our Order Book are considered at risk related to customer operations.
The Order Book is the estimated aggregate dollar amount of revenue for future SWU and uranium deliveries, and includes approximately $0.3 billion of deferred revenue and advances from customers as of December 31, 2023, whereby customers have made advance payments to be applied against future deliveries. No orders in our Order Book are considered at risk related to customer operations.
Refer to Note 16, Commitments and Contingencies, of the Consolidated Financial Statements in Part IV of this Annual Report for additional information. In addition, Centrus has entered into multiple inventory loans that we expect to repay from 2023 through 2025. Refer to Note 4, Inventories, of the Consolidated Financial Statements in Part IV of this Annual Report for additional information.
Refer to Note 17, Commitments and Contingencies, of the Consolidated Financial Statements in Part IV of this Annual Report for additional information. In addition, Centrus has entered into multiple inventory loans that we expect to repay from 2024 through 2026. Refer to Note 4, Inventories, of the Consolidated Financial Statements in Part IV of this Annual Report for additional information.
Ten reactors in Japan have restarted and an additional seven are expected to restart in 2023; more of Japan’s reactors are expected to restart in subsequent years. Due to the war in Ukraine, the EU is encouraging its member countries to reconsider the planned early retirement of existing plants in order to reduce reliance on Russian gas imports.
Eleven reactors in Japan have restarted and additional reactors are expected to restart through 2024; more of Japan’s reactors are expected to restart in subsequent years. Due to the war in Ukraine, the EU is encouraging its member countries to reconsider the planned early retirement of existing plants in order to reduce reliance on Russian gas imports.
Contracts where we sell both the SWU and natural uranium component of LEU to utilities or where we sell natural uranium to utilities and other nuclear fuel related companies are generally shorter-term, fixed-commitment contracts. Individual customer orders for the SWU component of LEU fulfilled in 2022 averaged approximately $10 million per order.
Contracts where we sell both the SWU and natural uranium hexafluoride components of LEU to utilities or where we sell natural uranium hexafluoride to utilities and other nuclear fuel related companies are generally shorter-term, fixed-commitment contracts. Individual customer orders for the SWU component of LEU fulfilled in 2023 averaged approximately $7.1 million per order.
Accordingly, we continue to monitor the situation closely and assess the potential impact of any new sanctions and how the impact on the Company might be mitigated.
Given all the foregoing, we continue to monitor the situation closely and assess the potential impact of any new sanctions and how the impact on the Company might be mitigated.
A one-half percentage point decrease in the expected return on plan assets would increase annual pension costs by $2.3 million in 2023.
A one-half percentage point decrease in the expected return on plan assets would increase annual pension costs by $1.3 million in 2024.
A one-half percentage point reduction in the discount rate would increase the valuation of pension benefit obligations by $21.7 million and postretirement health and life benefit obligations by $3.7 million, and the resulting changes in the valuations would decrease the aggregate service cost and interest cost components of annual pension costs and postretirement health and life benefit costs by $1.4 million and $0.3 million, respectively. • The healthcare costs trend rates are 7% projected in 2023 reducing to a final trend rate of 5% by 2031.
A one-half percentage point reduction in the discount rate would increase the valuation of pension benefit obligations by $13.0 million and postretirement health and life benefit obligations by $3.7 million, and the resulting changes in the valuations would decrease the aggregate service cost and interest cost components of annual pension costs and postretirement health and life benefit costs by $0.9 million and $0.3 million, respectively. • The healthcare costs trend rates are 7% projected in 2024 reducing to a final trend rate of 5% by 2032.
The expanding sanctions imposed by the United States and foreign governments on the mechanisms used to make payments to Russia and to obtain services including transportation and other services have increased the risk that implementation of the TENEX Supply Contract may be disrupted in the future.
In addition to limitations targeted specifically at imports of LEU, the expanding sanctions imposed by the United States and foreign governments on the mechanisms used to make payments to Russia and to obtain services including transportation and other services have increased the risk that implementation of the TENEX Supply Contract may be disrupted in the future.
Recent proposals to severely limit or cut off supply of LEU from Russia have drawn attention to the potential for significant tightening of supplies in the market. Russian enrichment plants represent 46% of the world’s capacity, and Russian capacity significantly exceeds its domestic needs.
Recent proposals, including proposed U.S. legislation, to severely limit or cut off supply of LEU from Russia have drawn attention to the potential for significant tightening of supplies in the market. Russian enrichment plants represent 44% of the world’s capacity, and Russian capacity significantly exceeds its domestic needs.
We have omitted discussion of 2020 results where it would be redundant to the discussion previously included in Item 7 of our 2021 Annual Report on Form 10-K, filed with the SEC on March 11, 2022.
We have omitted discussion of 2021 results where it would be redundant to the discussion previously included in Item 7 of our 2022 Annual Report on Form 10-K, filed with the SEC on February 22, 2023.
While sanctions imposed to date do not preclude the import of Russian uranium products into the United States, it is possible that additional restrictions could be added in the future that would affect our ability to purchase and resell Russian uranium 46 enrichment, which could have a negative material impact on our business.
While sanctions imposed to date do not preclude the import of Russian uranium products into the United States, it is possible that additional restrictions could be added in the future that would affect our ability to purchase and re-sell Russian uranium enrichment, or implement the TENEX Supply Contract, which could have a negative material impact on our business.
In 2021, Centrus evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that was required on Centrus’ federal deferred tax assets. As discussed in Operating Results, Centrus has visibility on a significant portion of revenue in the LEU segment through 2026, 53 primarily from its long-term sales contracts.
The Company evaluated both positive and negative evidence that was objectively verifiable to determine the amount of the federal valuation allowance that was required on Centrus’ federal deferred tax assets. Centrus has visibility on a significant portion of revenue in the LEU segment for 2023 through 2026, primarily from its long-term sales contracts.
SWU and Uranium Sales Revenue from our LEU segment accounted for approximately 80% of our total revenue for the year ended December 31, 2022. The majority of our customers are domestic and international utilities that operate nuclear power plants, with international sales constituting approximately 50% of revenue from our LEU segment since 2020.
SWU and Uranium Sales Revenue from our LEU segment accounted for approximately 84% of our total revenue for the year ended December 31, 2023. The majority of our customers are domestic and international utilities that operate nuclear power plants, with international sales constituting approximately 40% of revenue from our LEU segment since 2021.
The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 6 ¾ years of scheduled amortization remaining. The aggregate net balance of identifiable intangible assets was $45.7 million as of December 31, 2022.
The customer relationships intangible asset is amortized using the straight-line method over the estimated average useful life of 15 years, with 5 ¾ years of scheduled amortization remaining. The aggregate net balance of identifiable intangible assets was $39.4 million as of December 31, 2023.
Among the factors that could affect our results are the following: • Armed conflicts, including the war in Ukraine, government actions and other events or third-party actions that disrupt supply chains, production, transportation, payments, and importation of nuclear materials or other critical supplies or services; • The potential for sanctions and other measures affecting purchases of LEU, SWU or uranium, or goods or services required for the purchase or delivery of such LEU, SWU or uranium; • The availability and terms of additional purchases or sales of LEU, SWU and uranium; • Conditions in the LEU and energy markets, including pricing, demand, operations, government restrictions on imports, exports or investments, and regulations of our business and activities and those of our customers, suppliers, contractors, and subcontractors; 47 • Timing of customer orders, related deliveries, and purchases of LEU or its components; • Costs, future funding, and demand for HALEU; • Financial market conditions and other factors that may affect pension and benefit liabilities and the value of related assets; • The outcome of legal proceedings and other contingencies; • Potential use of cash for strategic or financial initiatives; • Actions taken by customers and suppliers, including actions that might affect existing contracts; • Market, international trade, and other conditions impacting Centrus’ customers and the industry; and • The length and severity of the COVID-19 pandemic and its impact on our operations.
Among the factors that could affect our results are the following: • Armed conflicts, including the war in Ukraine, government actions and other events or third-party actions that disrupt supply chains, production, transportation, payments, and importation of nuclear materials or other critical supplies or services; • The potential for sanctions and other measures affecting the importation, sales or purchases of SWU or uranium or goods or services required for the purchase or delivery of such SWU or uranium; 56 • The availability and terms of additional purchases or sales of SWU and uranium; • Conditions in the LEU and energy markets, including pricing, demand, operations, government restrictions on imports, exports or investments, and regulations of our business and activities and those of our customers, suppliers, contractors, and subcontractors; • Timing of customer orders, related deliveries, and purchases of LEU or LEU components; • Costs of and future funding and demand for HALEU; • Financial market conditions and other factors that may affect pension and benefit liabilities and the value of related assets; • The outcome of legal proceedings and other contingencies; • Potential use of cash for strategic or financial initiatives; • Actions taken by customers and suppliers, including actions that might affect existing contracts; • The government’s inability to satisfy its obligations, including supplying government furnished equipment under its agreements with the Company or processing security clearances due to a shutdown or other reasons; and • Market, international trade, and other conditions impacting Centrus’ customers and the industry.
Government for research, development and demonstration of gas centrifuge technology is reduced or discontinued, or we are not awarded a future DOE contract to continue to operate the cascade, such actions may have a material adverse impact on our ability to deploy the American Centrifuge technology and on our liquidity.
If funding of gas centrifuge technology by the U.S. government is reduced or discontinued, or we are not awarded a future DOE contract to continue to operate the cascade, such actions may have a material adverse impact on our ability to deploy the American Centrifuge technology and on our liquidity.
In connection with any such transaction, we may seek additional debt or equity financing, contribute or dispose of assets, assume additional indebtedness, or partner with other parties to consummate a transaction. Refer to Part I, Item 1, Business , for additional information.
In connection with any such transaction, we may seek additional debt or equity financing, contribute or dispose of assets, assume additional indebtedness, or partner with other parties to consummate a transaction.
The two parties agreed to extend the agreement through 2040 and to set aside a significant portion of the annual quota for Centrus’ shipments to the United States through 2028 to execute our long-term TENEX Supply Contract with TENEX. This outcome allows for sufficient quota for Centrus to continue serving its utility customers.
The two parties agreed to extend the agreement through 2040 and to set aside a significant portion of the annual quota for Centrus’ shipments to the United States through 2028 to execute our long-term TENEX Supply Contract with TENEX.
For the year ended December 31, 2022, the net actuarial loss reflected unfavorable investment returns relative to the expected return assumption, partially offset by an increase in interest rates from approximately 2.8% to 5.5%.
For the year ended December 31, 2022, the net actuarial loss reflected unfavorable investment returns relative to the expected return assumption, partially offset by an increase in interest rates from approximately 2.8% to 5.5%, favorable investment returns relative to the expected return assumption, and healthcare claims assumption, partially offset by changes in mortality, healthcare costs trend assumptions, and claims experience.
Therefore, Centrus recorded a $40.7 million partial release of its federal valuation allowance in the fourth quarter of 2021. In 2022, an analysis of the positive and negative evidence was performed to determine if a further change to the federal valuation allowance was necessary.
Therefore, Centrus recorded a $40.7 million partial release of its federal valuation allowance in the fourth quarter of 2021. Based on an analysis of the positive and negative evidence, it was determined that no change to the federal valuation allowance was necessary in 2022.
The decrease was primarily driven by a decrease in nonoperating components of net periodic benefit income of $61.0 million and an increase of income tax expense of $54.7 million, partially offset by an increase in gross profit of $3.4 million. 58 Net Income per Share Refer to Note 14, Net Income per Common Share, of the Consolidated Financial Statements in Part IV of this Annual Report.
The increase was primarily driven by an increase in nonoperating components of net periodic benefit income of $16.6 million, a decrease in income tax expense of $15.5 million, and an increase in investment income of $6.7 million, partially offset by a decrease in gross profit of $5.8 million. 67 Net Income per Share Refer to Note 15, Net Income per Common Share, of the Consolidated Financial Statements in Part IV of this Annual Report.
For details on HALEU Operation and Demonstration Contract accounting, refer to Technical Solutions - Government Contracting above. Gross Profit The Company recognized a gross profit of $117.9 million and in $114.5 million for the year ended December 31, 2022 and 2021, respectively, an improvement of $3.4 million (or 3%).
For details on HALEU Operation and Demonstration Contract accounting, refer to Technical Solutions - Government Contracting above. Gross Profit The Company recognized a gross profit of $112.1 million and $117.9 million for the year ended December 31, 2023 and 2022, respectively, a decrease of $5.8 million (or 5%).
In 2022, spot prices continued to increase substantially, reaching $110 per SWU by December 31, 2022. This represents an increase of 96% since the beginning of the year and 224% over the 2018 historic low.
In 2023, spot prices continued to increase, reaching $155 per SWU by December 31, 2023. This represents an increase of 41% since the beginning of the year and 356% over the 2018 historic low.
Three Months Ended December 31, Year Ended December 31, 2022 2021 2020 2022 2021 2020 Numerator (in millions): Net income $ 21.3 $ 116.2 $ 16.4 $ 52.2 $ 175.0 $ 54.4 Less: Distributed earnings allocable to warrant modification 1.5 — — 1.5 — — Less: Preferred stock dividends - undeclared and cumulative — — 0.8 — 2.1 6.7 Less: Distributed earnings allocable to retired preferred shares — 31.0 41.9 — 37.6 41.9 Net income (loss) allocable to common stockholders $ 19.8 $ 85.2 $ (26.3) $ 50.7 $ 135.3 $ 5.8 Plus: Distributed earnings allocable to warrant modification $ 1.5 $ — $ — $ 1.5 $ — $ — Plus: Distributed earnings allocable to retired preferred shares — 31.0 41.9 — 37.6 41.9 Adjusted net income, including distributed earnings allocable to retired preferred shares (Non-GAAP) $ 21.3 $ 116.2 $ 15.6 $ 52.2 $ 172.9 $ 47.7 Denominator (in thousands) (a): Average common shares outstanding - basic 14,648 13,873 10,322 14,601 13,493 9,825 Average common shares outstanding - diluted (b) 15,029 14,278 10,322 14,988 13,879 10,123 Net Income (Loss) per Share (in dollars): Basic $ 1.35 $ 6.14 $ (2.55) $ 3.47 $ 10.03 $ 0.59 Diluted $ 1.32 $ 5.97 $ (2.55) $ 3.38 $ 9.75 $ 0.57 Plus: Effect of distributed earnings allocable to retired preferred shares and warrant modification, per common share (in dollars): Basic $ 0.10 $ 2.24 $ 4.06 $ 0.11 $ 2.78 $ 4.26 Diluted $ 0.10 $ 2.17 $ 4.01 $ 0.10 $ 2.71 $ 4.14 Adjusted Net Income per Share (Non-GAAP) (in dollars): Basic $ 1.45 $ 8.38 $ 1.51 $ 3.58 $ 12.81 $ 4.85 Diluted $ 1.42 $ 8.14 $ 1.46 $ 3.48 $ 12.46 $ 4.71 (a) For details related to average shares outstanding, refer to Note 14 , Net Income Per Common Share, of the Consolidated Financial Statements.
Three Months Ended December 31, Year Ended December 31, 2023 2022 2021 2023 2022 2021 Numerator (in millions): Net income $ 56.3 $ 21.3 $ 116.2 $ 84.4 $ 52.2 $ 175.0 Less: Distributed earnings allocable to warrant modification — 1.5 — — 1.5 — Less: Preferred stock dividends - undeclared and cumulative — — — — — 2.1 Less: Distributed earnings allocable to retired preferred shares — — 31.0 — — 37.6 Net income allocable to common stockholders $ 56.3 $ 19.8 $ 85.2 $ 84.4 $ 50.7 $ 135.3 Plus: Distributed earnings allocable to warrant modification $ — $ 1.5 $ — $ — $ 1.5 $ — Plus: Distributed earnings allocable to retired preferred shares — — 31.0 — — 37.6 Adjusted net income, including distributed earnings allocable to retired preferred shares and warrant modification (Non-GAAP) $ 56.3 $ 21.3 $ 116.2 $ 84.4 $ 52.2 $ 172.9 Denominator (in thousands) (a): Average common shares outstanding - basic 15,461 14,648 13,873 15,212 14,601 13,493 Average common shares outstanding - diluted 15,732 15,029 14,278 15,501 14,988 13,879 Net Income per Share (in dollars): Basic $ 3.64 $ 1.35 $ 6.14 $ 5.55 $ 3.47 $ 10.03 Diluted $ 3.58 $ 1.32 $ 5.97 $ 5.44 $ 3.38 $ 9.75 Plus: Effect of distributed earnings allocable to retired preferred shares and warrant modification, per common share (in dollars): Basic $ — $ 0.10 $ 2.24 $ — $ 0.11 $ 2.78 Diluted $ — $ 0.10 $ 2.17 $ — $ 0.10 $ 2.71 Adjusted Net Income per Share (Non-GAAP) (in dollars): Basic $ 3.64 $ 1.45 $ 8.38 $ 5.55 $ 3.58 $ 12.81 Diluted $ 3.58 $ 1.42 $ 8.14 $ 5.44 $ 3.48 $ 12.46 (a) For details related to average shares outstanding, refer to Note 15 , Net Income Per Common Share, of the Consolidated Financial Statements in Part IV of this Annual Report. 68 Liquidity and Capital Resources As of December 31, 2023, the Company had a consolidated cash balance of $201.2 million.
The HALEU Operation Contract provides for a 50/50 cost share contract for Phase 1 of the base contract to complete the cascade, begin operations and complete the initial, small quantity demonstration HALEU. Phase 2 includes continued operations and maintenance on a cost-plus-incentive-fee basis.
We were awarded the HALEU Operation Contract in November 2022 which provided for a 50/50 cost share for Phase 1 of the base contract to complete the cascade, begin operations and complete the initial, small quantity of demonstration HALEU. The Company completed Phase 1 in November 2023. Phase 2 includes continued operations and maintenance on a cost-plus-incentive-fee basis.
Centrus has obligations related to our 8.25% Notes that mature in February 2027, as discussed above. We are also obligated to make payments under operating leases that expire at various dates through 2027. Refer to Note 9, Leases , of the Consolidated Financial Statements in Part IV of this Annual Report for further information.
We are also obligated to make payments under operating leases that expire at various dates through 2027. Refer to Note 9, Leases , of the Consolidated Financial Statements in Part IV of this Annual Report for further information.
Published spot price indicators for SWU reached historic highs in April 2009 at $163 per SWU. In the years following the 2011 Fukushima accident in Japan, spot prices declined more than 75%, bottoming out in August 2018 at $34 per SWU. This was followed by a slow and steady rise, reaching $56 per SWU by December 31, 2021.
In the years following the 2011 Fukushima accident in Japan, spot prices declined more than 75%, bottoming out in August 2018 at $34 per SWU. This was followed by a slow and steady rise, reaching $56 per SWU by December 31, 2021. In 2022, spot prices increased substantially, reaching $110 per SWU by December 31, 2022.
On November 23, 2021, the Company announced the results of the tender offer and the related Consent Solicitation to amend the certificate of designation of the Series B Senior Preferred Stock (the “Series B Preferred Amendment”). 36,867 shares of the Series B Senior Preferred Stock were properly tendered and not properly withdrawn in the Offer, and corresponding consents have been delivered in the Consent Solicitation.
The aggregate liquidation preference per Series B Senior Preferred Stock (including accrued but unpaid dividends) was $1,347.29 as of September 30, 2021. 73 On November 23, 2021, the Company announced the results of the tender offer and the related Consent Solicitation to amend the certificate of designation of the Series B Senior Preferred Stock (the “Series B Preferred Amendment”). 36,867 shares of the Series B Senior Preferred Stock were properly tendered and not properly withdrawn in the Offer, and corresponding consents have been delivered in the Consent Solicitation.
Changes in the competitive landscape affect pricing trends, change customer spending patterns, and create uncertainty. To address these changes, we have taken steps to adjust our cost structure; we may seek further adjustments to our cost structure and operations and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions.
To address these changes, we have taken steps to adjust our cost structure; we may seek further adjustments to our cost structure and operations and evaluate opportunities to grow our business organically or through acquisitions and other strategic transactions.
The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset.
The carrying amount of a long-lived asset is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. An impairment loss is measured as the amount by which the carrying amount of a long-lived asset, or asset group exceeds its fair value.
The Company intends to use the net proceeds from the sale of its common stock offered under this prospectus supplement for working capital and general corporate purposes including, but not limited to, capital expenditures, working capital, repayment of indebtedness, potential acquisitions and other business opportunities.
Unless otherwise specified in any prospectus supplement, we currently intend to use the net proceeds from the sale of our securities offered under this prospectus for working capital and general corporate purposes including, but not limited to, capital expenditures, working capital, repayment of indebtedness, potential acquisitions and other business opportunities.
Additionally, in 2021, the Company recorded direct costs of $0.3 million related to the issuance. The shares of Class A Common Stock were issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and a prospectus supplement dated December 31, 2020, to the prospectus.
The shares of Class A Common Stock were issued pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-239242), which became effective on August 5, 2020, and two prospectus supplements dated December 31, 2020 and December 5, 2022, respectively.
Pending any specific application, the Company may initially invest funds in short-term marketable securities or apply them to the reduction of indebtedness. The Company has not sold any shares under this ATM offering.
Pending any specific application, we may initially invest funds in short-term marketable securities or apply them to the reduction of indebtedness.
Revenue We have two reportable segments: the LEU segment and the Technical Solutions segment. Revenue from our LEU segment is derived primarily from: • sales of the SWU component of LEU; • sales of natural uranium; and • sales of enriched uranium product that include both the natural uranium and SWU components of LEU.
Revenue from our LEU segment is derived primarily from: • sales of the SWU component of LEU; • sales of natural uranium hexafluoride, uranium concentrates or uranium conversion; and • sales of enriched uranium product that include both the natural uranium hexafluoride and SWU components of LEU.
For the year ended December 31, 2020, the net actuarial loss reflected a decline in market interest rates from approximately 3.3% to 2.5%, partially offset by favorable investment returns relative to the expected return assumption and changes in mortality and healthcare claim assumptions.
For the year ended December 31, 2023, the net actuarial gain reflected favorable investment returns relative to the expected return assumption, partially offset by a decrease in interest rates from approximately 5.5% to 5.2%.
See Note 3 , Cash, Cash Equivalents, Restricted Cash of the Consolidated Financial Statements in Part IV of this Annual Report. The Company anticipates having adequate liquidity to support our business operations for at least the next 12 months from the date of this report.
The Company anticipates having adequate liquidity to support our business operations for at least the next 12 months from the date of this Annual Report.
The HALEU Demonstration Contract was originally set to expire on June 1, 2022; however, it was extended through November 30, 2022. The DOE elected to change the scope of the HALEU Demonstration Contract and moved the operational portion of the demonstration to a new, competitively-awarded contract that would provide for operations beyond the term of the existing HALEU Demonstration Contract.
The DOE elected to change the scope of the HALEU Demonstration Contract and moved the operational portion of the demonstration to a new, competitively-awarded contract that would provide for operations beyond the term of the existing HALEU Demonstration Contract.
The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse.
In assessing the realization of deferred tax assets, we determine whether it is more likely than not that the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon generating sufficient taxable income in future years when deferred tax assets are recoverable or are expected to reverse.
Segment Information The following tables present elements of the accompanying Consolidated Statements of Operations that are categorized by segment (dollar amounts in millions): Year Ended December 31, 2022 Compared with Year Ended December 31, 2021 Year Ended December 31, 2022 2021 $ Change % Change LEU segment Revenue: SWU revenue $ 196.2 $ 163.3 $ 32.9 20 % Uranium revenue 39.4 22.8 16.6 73 % Total 235.6 186.1 49.5 27 % Cost of sales 105.0 113.1 (8.1) (7) % Gross profit $ 130.6 $ 73.0 $ 57.6 79 % Technical Solutions segment Revenue $ 58.2 $ 112.2 $ (54.0) (48) % Cost of sales 70.9 70.7 0.2 — % Gross profit (loss) $ (12.7) $ 41.5 $ (54.2) (131) % Total Revenue $ 293.8 $ 298.3 $ (4.5) (2) % Cost of sales 175.9 183.8 (7.9) (4) % Gross profit $ 117.9 $ 114.5 $ 3.4 3 % Revenue Revenue from the LEU segment was $235.6 million and $186.1 million for the year ended December 31, 2022 and 2021, respectively, an increase of $49.5 million (or 27%).
Segment Information The following table presents elements of the accompanying Consolidated Statements of Operations that are categorized by segment (dollar amounts in millions): Year Ended December 31, 2023 Compared with Year Ended December 31, 2022 Year Ended December 31, 2023 2022 $ Change % Change LEU segment Revenue: SWU revenue $ 208.2 $ 196.2 $ 12.0 6 % Uranium revenue 60.8 39.4 21.4 54 % Total 269.0 235.6 33.4 14 % Cost of sales 163.9 105.0 58.9 56 % Gross profit $ 105.1 $ 130.6 $ (25.5) (20) % Technical Solutions segment Revenue $ 51.2 $ 58.2 $ (7.0) (12) % Cost of sales 44.2 70.9 (26.7) (38) % Gross profit (loss) $ 7.0 $ (12.7) $ 19.7 155 % Total Revenue $ 320.2 $ 293.8 $ 26.4 9 % Cost of sales 208.1 175.9 32.2 18 % Gross profit $ 112.1 $ 117.9 $ (5.8) (5) % 64 Revenue Revenue from the LEU segment was $269.0 million and $235.6 million for the year ended December 31, 2023 and 2022, respectively, an increase of $33.4 million (or 14%).
Common Stock Issuance The Company sold at the market price an aggregate of 99,090 shares and 1,516,467 shares of its Class A Common Stock for a total of $3.8 million and $44.2 million in 2022 and 2021, respectively. After expenses and commissions paid to the agents in 2022 and 2021, the Company’s proceeds total $3.6 million and $42.4 million, respectively.
Common Stock Issuance Pursuant to a sales agreement with its agents, the Company sold through at the market offerings an aggregate of 722,568 shares, 99,090 shares, and 1,516,467 shares of its Class A Common Stock for a total of $24.4 million, $3.8 million, and $44.2 million in 2023, 2022, and 2021, respectively.
In the IEA’s 2022 World Energy Outlook , nuclear generation is forecasted to grow by 25 percent by 2030 and 46 percent by 2040 under the “Stated Policies” scenario. In the “Net Zero Emissions by 2050” scenario, nuclear generation would grow by 46 percent by 2030 and more than double by 2040.
In the IEA’s 2023 World Energy Outlook , nuclear generation is forecasted to grow by 25 percent by 2030 and 45 percent by 2040 under the “Stated Policies” scenario.
For further discussion, refer to Part I, Item 1A, Risk Factors . If funding by the U.S.
For further discussion, refer to Part I, Item 1A, Risk Factors .
If we pursue opportunities that require capital, we believe we would seek to satisfy these needs through a combination of working capital, cash generated from operations or additional debt or equity financing.
In connection with any such transaction, we would seek to satisfy these needs through a combination of working capital, cash generated from operations or additional debt or equity financing.